DNA Phenotyping and RNA Profiling in Forensic Science
UGC-NET Paper 2 Unit III notes on forensic DNA phenotyping (HIrisPlex-S, Parabon Snapshot), RNA body-fluid panels, biogeographic ancestry and ethics.
Last updated:
Forensic DNA phenotyping (FDP) and RNA profiling are the two newest tools the syllabus packs into Unit III. STR analysis tells you whose DNA is on the swab, but only if you already have a reference or a database hit. FDP and RNA profiling answer what comes before that: what does the unknown contributor probably look like, and what body fluid is the stain made of. Both run on the same NGS hardware CFSL DNA divisions are now installing, so NTA has folded them in as an emerging-techniques bullet.
Treat this topic as a vocabulary plus applications drill. Recognise the kit names (HIrisPlex-S, IDseek HID, Parabon Snapshot, MiSeq FGx), the molecules (SNPs for FDP, mRNA and miRNA for body-fluid ID), and the ethical and legal limits on using either in an Indian courtroom.
- Forensic DNA phenotyping (FDP)
- Prediction of externally visible characteristics, ancestry and age of an unknown donor from SNP genotypes. Investigative lead, not identification.
- Externally visible characteristics (EVCs)
- Traits a witness could see: eye, hair, skin colour, freckling, hair shape, height. The EU-funded VISAGE consortium targets this set.
- SNP
- Single Nucleotide Polymorphism. A one-base variant at a defined position. FDP uses SNP panels, not STRs.
- HIrisPlex-S
- Reference SNP panel for eye, hair and skin colour. 41 SNPs: 6 IrisPlex (eye), 18 added for HIrisPlex (hair), 17 for the S extension (skin).
- Biogeographic ancestry inference (BGA)
- Statistical assignment of a donor to continental ancestry groups using Ancestry-Informative SNPs (AIMs). Distinct from racial categorisation.
- Parabon Snapshot
- Commercial FDP service (Parabon NanoLabs, USA) that returns a predicted composite, ancestry, eye, hair and skin colour from crime-scene DNA.
- mRNA / miRNA
- Messenger and micro RNA. Forensic RNA profiling uses tissue-specific transcripts of both classes to identify body fluids.
- Body-fluid-specific transcripts
- RNA markers expressed only in one fluid: HBB for blood, STATH for saliva, PRM1 for semen, MUC4 for vaginal fluid, MMP7 for menstrual blood.
- Deconvolution
- Statistical separation of a mixed profile (DNA or RNA) into individual contributor profiles.
Why both: STR profiling needs a reference; FDP and RNA profiling do not
The investigative-lead use case the syllabus is pointing at.
Classical STR profiling, covered in the Unit III DNA structure, extraction and profiling techniques bullet, is a comparison method. You run the crime-scene profile against a suspect or a database (CODIS, or the Indian National DNA Database under the DNA Technology Bill framework). No match, no answer.
Forensic DNA phenotyping fills the gap on the front end. From the same swab, FDP returns a probabilistic description of the unknown donor: most likely eye colour, hair colour, skin colour, biogeographic ancestry, and, with methylation assays, approximate age. None of this identifies the person; it narrows the suspect pool the way an eyewitness description would, but from the biology itself.
RNA profiling fills a parallel gap on the sample side. STR profiling tells you whose cells are on the swab; it does not tell you whether those cells came from blood, saliva, semen, vaginal epithelium or menstrual blood. That distinction often decides the charge, and the classical presumptive tests have known specificity problems. mRNA and miRNA panels read the transcript signature of the fluid directly.
The exam framing is straightforward: FDP and RNA profiling are investigative aids, not standalone identification evidence.
| Axis | Forensic DNA phenotyping | RNA profiling |
|---|---|---|
| Target molecule | Genomic DNA (SNPs, CpG sites) | mRNA and miRNA transcripts |
| What it predicts |
DNA phenotyping basics: SNP panels, ancestry and age
Four prediction targets, four marker classes.
FDP rests on the observation that a small number of well-chosen SNPs explain most of the heritable variation in a few visible traits. The panels and their targets:
| Trait | Reference panel | Markers | Performance |
|---|---|---|---|
| Eye colour | IrisPlex (2011) | 6 SNPs | ~94% AUC blue/brown |
| Hair colour | HIrisPlex (2013) | 24 SNPs | Red predicted best |
| Skin colour | HIrisPlex-S (2018) | 41 SNPs total | Strong at extremes |
| Biogeographic ancestry | AIM panels (Kidd, EUROFORGEN) | 55-170 SNPs | Continental robust |
| Age | Methylation (ELOVL2, FHL2) | 5-7 CpG sites | ±3-5 years (blood) |
Tools and pipelines (kit to prediction)
The names that show up in MCQs.
The end-to-end FDP workflow is: DNA extraction, targeted SNP library preparation, NGS sequencing, then prediction software. The kit names and platforms NTA tends to test:
| Stage | Representative tool | Function |
|---|---|---|
| Library preparation | ForenSeq DNA Signature Prep; IDseek HID; Precision ID Ancestry | Multiplex amplification of SNPs, STRs, Y-markers. |
| Sequencing | MiSeq FGx (Verogen); Ion S5 (Thermo) | Forensic NGS run, 150-250 bp reads. |
| Variant calling | ForenSeq Universal Analysis Software; Converge | Genotype calls plus QC. |
| Phenotype prediction | HIrisPlex-S web tool (Erasmus MC); Snipper | Eye/hair/skin colour and ancestry probabilities. |
| Commercial service | Parabon Snapshot (Parabon NanoLabs) | End-to-end: sample in, composite plus EVCs plus kinship out. |
Two facts to lock in: MiSeq FGx is the dedicated forensic NGS sequencer (Illumina MiSeq chemistry, validated for ForenSeq), and
RNA profiling for body-fluid identification
mRNA and miRNA panels against the classical presumptive tests.
The classical body-fluids workflow relies on colour-change presumptive tests (Kastle-Meyer, acid phosphatase, amylase) followed by confirmatory tests (Takayama, p30/PSA, microscopy). The colour tests are sensitive but not specific. RNA profiling answers the body-fluid question by reading the transcripts that are highly expressed only in that fluid.
mRNA markers (tissue-specific, co-extracted with DNA):
- Blood: HBA, HBB, ALAS2, CD93.
- Saliva: STATH (statherin), HTN3 (histatin), MUC7.
- Semen: PRM1, PRM2 (protamines), TGM4, KLK3.
- Vaginal secretion: MUC4, HBD1, LCN1.
- Menstrual blood: MMP7, MMP10, MMP11 (matrix metalloproteinases).
miRNA markers are much shorter (~22 nt) and considerably more stable in degraded samples than mRNA. Standard markers include miR-451 / miR-144 for blood, miR-205 for saliva, miR-891a for semen and miR-412 for menstrual blood. miRNA is the answer to "which RNA class survives best in aged stains?".
Advantages over classical serology: higher specificity, the ability to identify menstrual blood specifically (classical tests cannot separate menstrual from peripheral blood), and parallel processing on the same extract. Limitations: RNA lability, RT chemistry cost, and the absence of routine accredited deployment in Indian labs so far.
Ethics and the Indian context
Why FDP has limited admissibility in Indian courts so far.
FDP predicts traits the analyst can describe but never see, and generates group-level inferences (ancestry) that map uncomfortably onto categories with a history of misuse. The issues most often examined:
- Probabilistic, not deterministic. FDP returns a probability ("brown eyes, 87%"). Presenting a single colour as fact overstates the science.
- Biogeographic ancestry sensitivity. Continental ancestry can be confused for racial or caste categorisation; group-based suspect-pool framing is a real risk in a multi-ethnic country.
- Trait creep. The same SNP architecture could extend to behavioural or medical predictions. German and Dutch FDP laws explicitly cap the permitted traits.
- Population-database adequacy. Most FDP algorithms are under-trained on South Asian samples, weakening accuracy for Indian donors.
For Indian admissibility, the operative statute is the Bharatiya Sakshya Adhiniyam 2023, Section 39 of which governs expert opinion. The BSA does not specifically address FDP, and Indian courts have so far treated FDP outputs as investigative leads, not substantive identification evidence. The DNA Technology (Use and Application) Regulation Bill restricts permitted uses of DNA data to identification, missing persons, parentage and disaster-victim ID; phenotype prediction is not an enumerated purpose. CDFD and DFSS have flagged the need for an explicit regulatory frame before FDP enters routine casework.